Related references
Note: Only part of the references are listed.Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control
Anders Nissen Bonde et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Outcomes associated with warfarin time in therapeutic range among US veterans with nonvalvular atrial fibrillation
Shuqian Liu et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin
Keitaro Senoo et al.
STROKE (2016)
Outcomes in a Warfarin-Treated Population With Atrial Fibrillation
Fredrik Bjorck et al.
JAMA CARDIOLOGY (2016)
Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin The SAMe-TT2R2 Score
Stavros Apostolakis et al.
CHEST (2013)
The Danish Civil Registration System
Carsten Bocker Pedersen
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)
A. J. Rose et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
Stuart J. Connolly et al.
CIRCULATION (2008)
Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus. phenprocoumon
SD Fihn et al.
THROMBOSIS AND HAEMOSTASIS (2003)
Share Paper
